BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16313886)

  • 21. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue transglutaminase promotes or suppresses tumors depending on cell context.
    Chhabra A; Verma A; Mehta K
    Anticancer Res; 2009 Jun; 29(6):1909-19. PubMed ID: 19528447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.
    Mann AP; Verma A; Sethi G; Manavathi B; Wang H; Fok JY; Kunnumakkara AB; Kumar R; Aggarwal BB; Mehta K
    Cancer Res; 2006 Sep; 66(17):8788-95. PubMed ID: 16951195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
    Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
    Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress.
    Song H; Kim BK; Chang W; Lim S; Song BW; Cha MJ; Jang Y; Hwang KC
    J Recept Signal Transduct Res; 2011 Feb; 31(1):66-74. PubMed ID: 21067463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transglutaminase 2 contributes to apoptosis induction in Jurkat T cells by modulating Ca2+ homeostasis via cross-linking RAP1GDS1.
    Hsieh YF; Liu GY; Lee YJ; Yang JJ; Sándor K; Sarang Z; Bononi A; Pinton P; Tretter L; Szondy Z; Tsay GJ
    PLoS One; 2013; 8(12):e81516. PubMed ID: 24349085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell-T cell interaction.
    Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
    Cell Immunol; 2014; 289(1-2):55-62. PubMed ID: 24727157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembly of tissue transglutaminase into amyloid-like fibrils using physiological concentration of Ca2+.
    Kalhor HR; Shahin V F; Fouani MH; Hosseinkhani H
    Langmuir; 2011 Sep; 27(17):10776-84. PubMed ID: 21790128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
    Tatsukawa H; Kojima S
    Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
    She QB; Ma WY; Dong Z
    Oncogene; 2002 Feb; 21(10):1580-9. PubMed ID: 11896587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.
    Csosz E; Bagossi P; Nagy Z; Dosztanyi Z; Simon I; Fesus L
    J Mol Biol; 2008 Nov; 383(2):390-402. PubMed ID: 18761350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of tissue transglutaminase.
    Keillor JW; Apperley KY; Akbar A
    Trends Pharmacol Sci; 2015 Jan; 36(1):32-40. PubMed ID: 25500711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
    Nadella V; Wang Z; Johnson TS; Griffin M; Devitt A
    Biochim Biophys Acta; 2015 Jan; 1853(1):201-12. PubMed ID: 25449226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
    Park D; Choi SS; Ha KS
    Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.
    Poole LG; Kopec AK; Flick MJ; Luyendyk JP
    J Thromb Haemost; 2022 May; 20(5):1182-1192. PubMed ID: 35158413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.
    Lai TS; Lin CJ; Greenberg CS
    Amino Acids; 2017 Mar; 49(3):501-515. PubMed ID: 27270573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
    Rossin F; D'Eletto M; Macdonald D; Farrace MG; Piacentini M
    Amino Acids; 2012 May; 42(5):1793-802. PubMed ID: 21479826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways.
    Kojima S; Kuo TF; Tatsukawa H; Hirose S
    Dig Dis; 2010; 28(6):715-21. PubMed ID: 21525755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.